EQUITY UPDATE: Rosen Law Firm Reminds eHealth, Inc. Investors of Important Deadline in Class Action Filed by Firm -- EHTH


NEW YORK, Feb. 18, 2015 (GLOBE NEWSWIRE) -- The Rosen Law Firm, a global investor rights firm, reminds purchasers of eHealth, Inc. stock (Nasdaq:EHTH) between October 31, 2014 and January 14, 2015 of the important March 27, 2015 lead plaintiff deadline in the class action filed by the firm.

To join the eHealth class action, go to the website at http://www.rosenlegal.com/cases-479.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or kchan@rosenlegal.com for information on the class action. The suit is pending in U.S. District Court for the Northern District of California.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.

According to the lawsuit, eHealth and certain of its officers and directors issued materially false and misleading statements about the Company's true financial condition and prospects. On January 14, 2015, eHealth lowered its fiscal year 2014 revenue guidance to a range of $178 to $180 million from its prior revenue guidance in the range of $185 million to $194 million. The Company attributed the revision in part to lower than expected applications for its Individual & Family Plan. On this news, shares of eHealth fell $11.38 per share or almost 55% from its previous closing price to close at $9.42 per share on January 14, 2015, damaging investors.

If you wish to join the class action to recover your losses go http://www.rosenlegal.com/cases-479.html or to discuss your rights or interests regarding this class action, please contact, Phillip Kim, Esq. or Kevin Chan, Esq. of The Rosen Law Firm toll free at 866-767-3653 or via e-mail at pkim@rosenlegal.com or kchan@rosenlegal.com.

The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.



            

Contact Data